GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (OTCPK:BMNDF) » Definitions » Short Interest

BMNDF (Biomind Labs) Short Interest


View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Biomind Labs's Short Interest

For the Biotechnology subindustry, Biomind Labs's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomind Labs's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomind Labs's Short Interest distribution charts can be found below:

* The bar in red indicates where Biomind Labs's Short Interest falls into.


;
;

Biomind Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (OTCPK:BMNDF) » Definitions » Short Interest
Comparable Companies
TSXV:TTI TSXV:GSD XCNQ:DOSE TSX:HBP TSX:BCT XCNQ:PHRM XCNQ:TELI TSXV:NRX XCNQ:MDMA TSX:SVA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
3XI:Germany BMND:Canada
Address
Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000
Website
https://www.biomindlabs.com
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.